Metastatic Sinonasal Squamous Cell Carcinoma

2 clinical trials · Condition

Record	Firm	Date
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer (NCT06868433)	Emory University	2025-05-08
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers (NCT05063552)	National Cancer Institute (NCI)	2023-03-13

Every clearance here is in the API, with alerts when new ones post.